Skip to main navigation Skip to search Skip to main content

MHC class I transactivator NLRC5 in host immunity, cancer and beyond

  • Steven X. Cho
  • , Saptha Vijayan
  • , Ji Seung Yoo
  • , Toshiyuki Watanabe
  • , Ryota Ouda
  • , Ning An
  • , Koichi S. Kobayashi
  • Hokkaido University
  • Texas A&M University

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations

Abstract

The presentation of antigenic peptides by major histocompatibility complex (MHC) class I and class II molecules is crucial for activation of the adaptive immune system. The nucleotide-binding domain and leucine-rich repeat receptor family members CIITA and NLRC5 function as the major transcriptional activators of MHC class II and class I gene expression, respectively. Since the identification of NLRC5 as the master regulator of MHC class I and class-I-related genes, there have been major advances in understanding the function of NLRC5 in infectious diseases and cancer. Here, we discuss the biological significance and mechanism of NLRC5-dependent MHC class I expression.

Original languageEnglish
Pages (from-to)252-261
Number of pages10
JournalImmunology
Volume162
Issue number3
DOIs
StatePublished - Mar 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cancer immune evasion
  • class I transactivator
  • major histocompatibility complex class I
  • regulatory factor X

Fingerprint

Dive into the research topics of 'MHC class I transactivator NLRC5 in host immunity, cancer and beyond'. Together they form a unique fingerprint.

Cite this